Assembly Biosciences, Inc. (ASMB) Institutional Ownership

Ownership Summary

Assembly Biosciences, Inc. (NASDAQ:ASMB) appears in 1 institutional 13F filings for the quarter ending March 2024.

• They owned 0.0% of outstanding stock in March 2024, down from 239.2% the prior quarter.
• They maintained total shares held in ASMB by 0.0% quarter over quarter, and investors in Assembly Biosciences decreased 97.44% from a year ago.
• Of these 1 holders, 0 added to their stakes in Assembly Biosciences, 0 trimmed positions, and 1 made no changes.
• Altogether, these fund groups held 664 shares in ASMB by March 2024, with no net change quarter on quarter, and down 15.44Mn shares year over year.
• Gilead Sciences, Inc. leads ownership in ASMB with 4.51Mn shares as of March 31, 2024, equal to 82.17% of outstanding shares.
• The most significant purchases of ASMB for the quarter ending March 2024 came from Paradigm Biocapital Advisors LP (665.25K), Point72 Asset Management, L.P. (304.59K), ADAGE CAPITAL PARTNERS GP, L.L.C. (161.0K), Eversept Partners, LP (159.68K), Caption Management, LLC (106.59K).
• The largest sales of ASMB for the quarter ending March 2024 came from FARALLON CAPITAL MANAGEMENT LLC (1.23Mn), RENAISSANCE TECHNOLOGIES LLC (144.37K), Blackstone Inc. (129.04K), Schonfeld Strategic Advisors LLC (67.65K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (50.63K).
• Assembly Biosciences's 10 largest shareholders as of March 2024 include Gilead Sciences, Inc. (4.51Mn), FARALLON CAPITAL MANAGEMENT LLC (1.23Mn), RA CAPITAL MANAGEMENT, L.P. (1.02Mn), Commodore Capital LP (1.0Mn), Janus Henderson Group Plc (837.92K), Paradigm Biocapital Advisors LP (665.25K), Point72 Asset Management, L.P. (600.61K), VANGUARD GROUP INC (572.9K), Blackstone Inc. (318.75K), Franklin Resources Inc (210.53K) per Business Quant data.